@article{45aa043508c646019dfeb088cbc20002,
title = "Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI Trial",
abstract = "The initiation of disease-modifying pharmacological agents that also lower blood pressure in the period immediately after acute myocardial infarction (AMI)can be challenging. For sacubitril/valsartan, the extrapolation of safety and tolerability evidence to the acute illness setting is limited by the run-in phase of seminal outcome trials and their target population of patients with ambulatory chronic disease.",
keywords = "chronic disease, heart failure, myocardial infarction, physicians, valsartan",
author = "{De Pasquale}, {Carmine G.} and Brian Claggett and Karola Jering and McMurray, {John J.V.} and Douglas Mann and Miao, {Zi Michael} and Granger, {Christopher B.} and Lars K{\o}ber and Maggioni, {Aldo P.} and Jean-Lucien Rouleau and Solomon, {Scott D.} and Steg, {Philippe Gabriel} and {Van Der Meer}, Peter and Eugene Braunwald and Pfeffer, {Marc A.}",
year = "2024",
month = jul,
doi = "10.1161/CIRCHEARTFAILURE.123.011393",
language = "English",
volume = "17",
pages = "e011393",
journal = "Circulation: Heart Failure",
issn = "1941-3289",
publisher = "Lippincott Williams & Wilkins",
number = "7",
}
